Axcan to acquire QLTI's Photofrin

Axcan Pharma (Mont Saint Hillaire, Quebec) agreed to acquire worldwide rights to QLTI's Photofrin photodynamic therapy to treat cancers including esophageal and endobronchial cancers. Under the agreem...